Akpo, E. I. H., Cerri, K., & Kleintjens, J. (2015). Predicting the Impact of Adverse Events and Treatment Duration on Medical Resource Utilization-Related Costs in Hepatitis C Genotype 1 Treatment-Naïve Patients Receiving Antiviral Therapy. Pharmacoeconomics.
Citación estilo ChicagoAkpo, Essè Ifèbi Hervé, Karin Cerri, and Joris Kleintjens. "Predicting the Impact of Adverse Events and Treatment Duration On Medical Resource Utilization-Related Costs in Hepatitis C Genotype 1 Treatment-Naïve Patients Receiving Antiviral Therapy." Pharmacoeconomics 2015.
Cita MLAAkpo, Essè Ifèbi Hervé, Karin Cerri, and Joris Kleintjens. "Predicting the Impact of Adverse Events and Treatment Duration On Medical Resource Utilization-Related Costs in Hepatitis C Genotype 1 Treatment-Naïve Patients Receiving Antiviral Therapy." Pharmacoeconomics 2015.